吕建明

吕建明 is a declared insider of 通策医疗 (board member), with filings sourced from SSE / SZSE (CSRC). In total, 7 filings cover trades dated from 16 February 2022 to 18 December 2023.

Purchases make up the whole of the open-market record (7 purchases, €2.4M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €206k. The 7 purchases reviewed show no overlap with other insiders buying the same stock within a month. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 29% of cases, with a median move of -13.7%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 18 December 2023, reports an open-market purchase of €44k in 通策医疗. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.